Form 8-K - Current report:
SEC Accession No. 0001193125-22-213166
Filing Date
2022-08-05
Accepted
2022-08-05 08:09:56
Documents
15
Period of Report
2022-08-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d297804d8k.htm   iXBRL 8-K 27776
2 EX-99.1 d297804dex991.htm EX-99.1 155346
6 GRAPHIC g297804g0803220857091.jpg GRAPHIC 5825
7 GRAPHIC g297804snap1.jpg GRAPHIC 3162
  Complete submission text file 0001193125-22-213166.txt   336489

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vivo-20220805.xsd EX-101.SCH 2889
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vivo-20220805_lab.xml EX-101.LAB 17235
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vivo-20220805_pre.xml EX-101.PRE 10834
9 EXTRACTED XBRL INSTANCE DOCUMENT d297804d8k_htm.xml XML 3266
Mailing Address 3471 RIVER HILLS DRIVE CINCINNATI OH 45244
Business Address 3471 RIVER HILLS DR CINCINNATI OH 45244 5132713700
MERIDIAN BIOSCIENCE INC (Filer) CIK: 0000794172 (see all company filings)

EIN.: 310888197 | State of Incorp.: OH | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-14902 | Film No.: 221138671
SIC: 2835 In Vitro & In Vivo Diagnostic Substances